Dr. Paul Kelly is a Founding Partner of OneVentures, an Australian venture capital firm. See sector focus and contact routes.
Dr. Paul Kelly is a Founding Partner of OneVentures, an Australian venture capital firm, where he leads the Healthcare and Biotechnology practice with over 30 years of experience in biomedical innovation. His investment thesis centers on scaling technology and healthcare companies, specifically targeting sectors within life sciences, biotechnology, and medical devices across Australia, the United States, and Europe. Kelly typically acts as a deal lead for portfolio companies, having directly led investments in Hatchtech, Vaxxas, Clinical Genomics, Prota Therapeutics, and BiVACOR Inc. Notable named portfolio companies include Vaxxas, an immunology firm; BiVACOR, which develops artificial heart valves; Clinical Genomics, a cancer diagnostics company; and Prota Therapeutics, a biotechnology firm focused on skin diseases. He serves on the investment committees for Funds I through V and provides strategic guidance to companies while holding non-executive director roles at BiVACOR and Prota Therapeutics. Kelly distinguishes himself through a deep scientific background as a medical doctor and endocrinologist, having authored over 100 publications in leading jo
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Sydney.
Investors like Paul Kelly · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide